Talk:Mimotope

Latest comment: 3 years ago by Immcarle148 in topic Will be Updating this Site

Untitled edit

Contribution that does not really fit "When antibodies do not follow the protein background, the epitope's characterisation by a subsequence of the target protein is not possible. A synthetic oligopeptide mimicking the binding, or a series of these, then substitutes the original protein to work towards a molecular model of the binding." Anybody feeling stimulated to improve?

Smoe (talk) 11:35, 16 April 2010 (UTC)Reply

Will be Updating this Site edit

In the next few weeks I will be adding information and reorganizing this Wikipedia page. Here is a list of several sources (reviews) I intend to use:

1. Favoino E, Prete M, Marzullo A, Millo E, Shoenfeld Y, Perosa F. CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases. Clin Rev Allergy Immunol. 2017;52(2):217-233. doi:10.1007/s12016-016-8551-x
2. Huang J, He B, Zhou P. Mimotope-based prediction of B-cell epitopes. Methods Mol Biol. 2014;1184:237-243. doi:10.1007/978-1-4939-1115-8_13
3. Slansky JE, Nakayama M. Peptide mimotopes alter T cell function in cancer and autoimmunity. Semin Immunol. 2020;47:101395. doi:10.1016/j.smim.2020.101395
4. Luzar J, Štrukelj B, Lunder M. Phage display peptide libraries in molecular allergology: from epitope mapping to mimotope-based immunotherapy. Allergy. 2016;71(11):1526-1532. doi:10.1111/all.12965
5. Zhang D, Chen Y, Fan D. MG7 mimotope-based DNA vaccination for gastric cancer. Expert Rev Vaccines. 2006;5(2):223-231. doi:10.1586/14760584.5.2.223

--Immcarle148 (talk) 01:46, 29 January 2021 (UTC)Reply